Head to head
On Holding vs Nike
Side-by-side on the measures that matter, with a plain-English read. Full detail: ONON · NKE
ONON
On Holding
29.97-2.76%
1-year price shape — -28% over the period
Quant Rating E · 14/100
vs
NKE
Nike
32.92-4.11%
1-year price shape — -45% over the period
Quant Rating E · 7/100
1-year performance, rebased to 100
Nike edges it on the scoreable measures. Nike trades cheapest on trailing earnings; Nike pays the highest dividend yield; Nike earns the most per share.
| ONON | NKE | |
|---|---|---|
| Snapshot | ||
| Sector | Footwear & Accessories | Footwear & Accessories |
| Last price | 29.97 | 32.92 |
| Change today | -2.76% | -4.11% |
| 1-year return | -27.6% | -44.6% |
| Market cap | $10.02B | $48.90B |
| 52-week range | 26.37 – 51.08 | 31.97 – 67.36 |
| Valuation | ||
| P/E (TTM) | 19.31 | 15.75 |
| P/E percentile, own 5-yr range | 23rd | 0th |
| P/B | 3.89 | 3.21 |
| Dividend yield | 0.00% | 4.98% |
| Profitability & growth | ||
| EPS (TTM) | 0.72 | 2.10 |
| Net profit (TTM) | $241.64M | $3.12B |
| Revenue (TTM) | $3.36B | $45.89B |
| Provider revenue period date | 2026-09-29 | 2026-08-30 |
| Revenue growth (YoY) | +17.2% | -4.3% |
| Gross margin | 66.8% | 43.1% |
| Operating margin | 15.3% | 8.2% |
| Net margin | 13.1% | 6.7% |
| Free cash flow (TTM) | $413.20M | $2.11B |
| Provider cash-flow period date | 2026-09-29 | 2026-08-30 |
| Ownership & sentiment | ||
| Institutional ownership | 67.4% | 67.1% |
| Insider activity (12mo) | 20 buy / 28 sell | 26 buy / 23 sell |
| Short interest (% of float) | 8.8% | 6.3% |
| Analyst consensus | 85% buy / 11% hold / 4% sell (27) | 28% buy / 44% hold / 28% sell (32) |
| Analyst price target | $44 (+47%) | $39 (+17%) |
| StockVane view | ||
| StockVane Quant Rating | E (14) | E (7) |
| Company | ||
| Employees | 3,963 | 73,000 |
| Founded | 2012 | 1967 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.